Dual effects of lysophosphatidic acid on human airway smooth muscle cell proliferation and survival

被引:13
作者
Ediger, TL [1 ]
Toews, ML [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2001年 / 1531卷 / 1-2期
关键词
airway smooth muscle cell; lysophosphatidic acid; extracellular Ca2+; apoptosis; proliferation;
D O I
10.1016/S1388-1981(01)00084-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lysophosphatidic acid (LPA) is a phospholipid growth mediator found in serum at 2-20 muM. In many cell types, including human airway smooth muscle (HASM) cells, LPA-induced proliferation occurs at 10-100 muM LPA. At these concentrations LPA forms Ca2+ precipitates. The potential involvement of Ca2+ and Ca2+-LPA precipitates in LPA-induced HASM cell mitogenesis was investigated. In the absence of extracellular Ca2+, 10 and 30 muM LPA stimulated HASM cell mitogenesis. However, with 100 muM LPA in the absence of extracellular Ca2+, HASM cells exhibited a profound shape change and loss of viability, determined to be apoptosis by both DNA staining and assessment of cytosolic nucleosomal reactivity. A bioassay based on the adenosine 3':5'-cyclic monophosphate response of C62B rat glioma cells was used to measure the bioactivity of LPA solutions prepared in Ca2+-free and Ca2+-containing medium. After 24 h, a 100 muM LPA solution in Ca2+-free medium contained markedly greater bioactivity than a 100 muM LPA solution made in Ca2+-containing medium. In summary, formation of Ca2+-LPA precipitates decreases the amount of biologically active LPA in solution, and high concentrations of bioactive LPA achieved in Ca2+-free but not in Ca2+-containing medium induce apoptosis of HASM cells. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:59 / 67
页数:9
相关论文
共 29 条
  • [1] Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor - Dependence on calcium and the actin cytoskeleton
    Brinson, AE
    Harding, T
    Diliberto, PA
    He, YQ
    Li, X
    Hunter, D
    Herman, B
    Earp, HS
    Graves, LM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (03) : 1711 - 1718
  • [2] Role of calcium in angiotensin II-Induced prostaglandin release and DNA synthesis in rat vascular smooth muscle cells
    Catalioto, RM
    Renzetti, AR
    Criscuoli, M
    Morbidelli, L
    Subissi, A
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (02) : 195 - 200
  • [3] Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells
    Cerutis, DR
    Nogami, M
    Anderson, JL
    Churchill, JD
    Romberger, DJ
    Rennard, SI
    Toews, ML
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 273 (01) : L10 - L15
  • [4] Frankel A, 1996, CLIN CANCER RES, V2, P1307
  • [5] Freshney R.A., 1987, CULTURE ANIMAL CELLS, VSecond
  • [6] Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells
    Gaits, F
    Salles, JP
    Chap, H
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (04) : 1022 - 1027
  • [7] Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate
    Goetzl, EJ
    An, SZ
    [J]. FASEB JOURNAL, 1998, 12 (15) : 1589 - 1598
  • [8] Goetzl EJ, 1999, J IMMUNOL, V162, P2049
  • [9] Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation
    Gueguen, G
    Gaigé, B
    Grévy, JM
    Rogalle, P
    Bellan, J
    Wilson, M
    Klaébé, A
    Pont, F
    Simon, MF
    Chap, H
    [J]. BIOCHEMISTRY, 1999, 38 (26) : 8440 - 8450
  • [10] JALINK K, 1993, CELL GROWTH DIFFER, V4, P247